Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Advanced Pharmaceutical Bulletin
ISSN: 2228-5881      eISSN: 2251-7308  
Services
Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks
Mendeley

Cite by
Google Scholar
PMC(0)


Article History
Submitted: 28 May 2014
Revised: 20 Jul 2014
First published online: 01 Jun 2015

Article Access Statistics
Abstract Page Views: 380
PDF Downloads: 168
Full Text Views: 0

Adv Pharm Bull. 2015;5(2):209-216 doi: 10.15171/apb.2015.029
PMID:26236659        PMCID:PMC4517077

Therapeutic Efficacy of Orally Delivered Doxorubicin Nanoparticles in Rat Tongue Cancer Induced by 4-Nitroquinoline 1-Oxide

Original Research

Monir Moradzadeh Khiavi 1, Ahamd Rostami 2, Hamed Hamishekar 3, Mehran Mesgari Abassi 3, Amirala Aghbali 2, Roya Salehi 3, Bita Abdollahi 3, Soheila Fotoohi 3, Mahmud Sina 2

1 Department of Oral and Maxillofacial Pathology, School of Dentistry, Tehran University of Medical Sciences, International campus, Tehran, Iran.
2 Department of Oral and Maxillofacial Pathology, School of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
3 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.



Abstract
Purpose: Oral cancer is one of the most significant cancers in the world, and squamous cell carcinoma makes up about 94% of oral malignancies. The aim of the present study was to compare the efficacy of doxorubicin plus methotrexate - loaded nanoparticles on tongue squamous cell carcinoma induced by 4NQO and compare it with the commercial doxorubicin and methotrexate delivered orally on seventy SD male rats. Methods: 70 rats were divided into five groups. During the study, the animals were weighed by a digital scale once a week. Number of mortalities was recorded in the data collection forms. At the end of the treatment, biopsy samples were taken from rat tongues in order to evaluate the severity of dysplasia and the extent of cell proliferation. The results were analyzed using ANOVA, descriptive statistics and chi-square test. Results: No statistically significant difference was found in the mean weight of five groups (p>0.05). No significant relationship was found between groups and mortality rate (P = 0. 39). In addition, there was a significant relationship between groups and the degree of dysplasia (P <0.001). The statistical analysis showed a significant relationship between groups and the rate of cell proliferation (p <0.001). Conclusion: The results of the present study showed that the use of doxorubicin plus methotrexate - loaded nanoparticles orally had more therapeutic effects than commercial doxorubicin plus methotrexate.





Comments
First name  
Last name  
Email address  
Comments  
Security code



This Article
PDF

Google Scholar
Articles by Moradzadeh Khiavi M
Articles by Rostami A
Articles by Hamishekar H
Articles by Mesgari Abassi M
Articles by Aghbali A
Articles by Salehi R
Articles by Abdollahi B
Articles by Fotoohi S
Articles by Sina M

PubMed
Articles by Moradzadeh Khiavi M
Articles by Rostami A
Articles by Hamishekar H
Articles by Mesgari Abassi M
Articles by Aghbali A
Articles by Salehi R
Articles by Abdollahi B
Articles by Fotoohi S
Articles by Sina M

Similar articles in PubMed

Share this article!

Press Manuscript Online. Powered by MAADRAYAN